Tamás Fehér is a partner with Jalsovszky Law Firm, the Hungarian member of the International Lawyers Network, where he practices…
Read More →
Some funding applications submitted to NIH beginning Jan. 25 will face new requirements and undergo a revised peer review process.…
Read More →
In December 2022, Julie Kaneshiro—then deputy director of the HHS Office for Human Research Protections (OHRP)—disclosed that the agency had…
Read More →
On March 22, 2024, the Federal Trade Commission (“FTC”) filed an amicus brief in Teva Branded Pharmaceutical Products R&D, et…
Read More →
Now that the European Parliament has approved the EU AI Act, you should understand how the broad AI regulation affects…
Read More →
We have all heard the terms “ambulance chasers” or “case runners” used to describe unethical practices of personal injury law…
Read More →
Intellectual property (“IP”) is typically monetized either by sale or (royalty generating) license agreements. The Code often allows sales to…
Read More →
Case Name: UCB, Inc. v. Mylan Techs. Inc., Civ. No. 22-cv-216 (D. Vt. Mar. 8, 2024) (Reiss, J.) – Drug…
Read More →
In a series of three articles, we will address the ascendency of account takeover (“ATO”) and business email compromise (“BEC”)…
Read More →
On April 29, 2024, the White House released a statement entitled, “Biden-Harris Administration Announces Key AI Actions 180 Days Following…
Read More →